Research conducted by Professor Anand Deva and Associate Professor Mark Magnusson shows the risk of developing a rare cancer called Breast Implant Associated – Anaplastic Large Cell Lymphoma (BIA – ALCL) is significantly higher with rough textured implants, with the highest increase in reported cases linked to the biocell textured implant made by Allergan. The implants used by the TCI companies were these Allergan biocell implants and in the class action brought by Turner Freeman against the TCI companies and Dr Eddy Dona, it is pleaded that by reason of TCI’s “One Size Fits All Approach” to BAS, women were at an increased risk of having several complications, including BIA – ALCL.
Please see below link to the full article in the Sunday Telegraph.
Register in our Class Action
We invite you to register your interest in the class action against TCI with Turner Freeman Lawyers. It is important that you put your hand up to be counted. If you have suffered complications as a result of surgery by TCI, please register on our website and our medical negligence Partner, Sally Gleeson or one of her team members will be in touch to explain the process.